A PYMNTS Company

U.S.: PhRMA accuses FTC of discriminating against industry

By  |  November 2, 2012

In response to the Federal Trade Commission’s decision to expand its jurisdiction over approving different types of exclusive pharmaceutical patent rights licenses, Pharmaceutical Research and Manufacturers of America has accused the FTC of exceeding its authority. Additionally, PhRMA has called for the FTC to dismiss the decision, arguing it discriminates against the pharmaceutical industry, and has asked the authority to change its premerger notification rules.

Full Content: Law360

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.